Counselor Attitudes Toward Pharmacotherapies for Alcohol Dependence
Counselor Attitudes Toward Pharmacotherapies for Alcohol Dependence
复制标题
DOI：
10.15288/jsad.2009.70.628
复制
发表时间：
2009-07-01
影响因子：
3.4
通讯作者：
Roman, Paul M.
中科院分区：
文献类型：
--
作者：
Abraham, Amanda J.;Ducharme, Lori J.;Roman, Paul M.
目的：成瘾治疗顾问在向酒精依赖患者传播新治疗技术的信息方面发挥着核心作用，也是实施新治疗技术的关键。在先前研究的基础上，这项研究调查了咨询师对治疗酒精依赖的药物疗法的有效性和可接受性的看法。方法：2006年，在具有全国代表性的公共部门成瘾治疗项目样本中，1140名咨询师接受了邮寄问卷调查。咨询师回答了有关美国食品和药物管理局(FDA)批准的三种用于治疗酒精依赖的药物(二硫氰胺[抗滥用]、纳曲酮[瑞维亚]和氨基己酸酯[Campral])的一系列问题，表明了他们对药物的熟悉程度，对酒精依赖治疗的感知有效性，以及对酒精依赖患者使用的可接受性。结果：这些药物的扩散程度与FDA批准后的时间有关。咨询师报告说，他们很少或根本没有接受过药物治疗方面的培训。多变量模型显示，接受针对药物的培训，以及在治疗计划中间接观察药物的使用情况，与这些药物疗法的信息传播和咨询者对用于成瘾治疗的药物的有效性和可接受性的看法显著相关。结论：当接触到治疗酒精依赖的药物信息时，咨询人员似乎很容易接受。需要作出更多努力，向前线成瘾治疗人员传播有关酒精药物疗法的信息。(J.Stud.酒精类毒品70：628-635,2009)
Objective: Addiction treatment counselors play a central role in the dissemination of information about new treatment techniques to alcohol-dependent patients and are key in the implementation of new treatment technologies. Building on previous research, this study examines counselors' perceptions of the effectiveness and acceptability of pharmacotherapies for the treatment of alcohol dependence. Method: Mail questionnaires were received from 1,140 counselors employed in a nationally representative sample of public-sector addiction treatment programs in 2006. Counselors answered a series of questions about three U.S. Food and Drug Administration (FDA)-approved medications used in the treatment of alcohol dependence (disulfirarn [Antabuse], tablet naltrexone [Revia], and acamprosate [Campral]), indicating their extent of familiarity with the medication, its perceived effectiveness in the treatment of alcohol dependence, and its acceptability for use with alcohol-dependent patients. Results: The extent of diffusion of these pharmacotherapies was associated with time since FDA approval. Counselors reported receiving little or no pharmacotherapy-specific training. Multivariate models showed that the receipt of medication-specific training as well as indirect observation of the medication's use in the treatment program were significantly associated with diffusion of information about these pharmacotherapies and counselors' perceptions of the effectiveness and acceptability of the medications for use in addiction treatment. Conclusions: When exposed to information about medications to treat alcohol dependence, counseling staff appear quite receptive. More efforts are needed to disseminate information about alcohol pharmacotherapies to front-line addiction treatment staff. (J. Stud. Alcohol Drugs 70: 628-635, 2009)